Grifols has dosed the first participant in a Phase 3 [...]

Grifols has launched Fesilty in the USA, making the fibrinogen [...]

Grifols has received US Food and Drug Administration (FDA) approval [...]

Grifols has received US FDA approval for an expanded indication [...]

Grifols’ Biotest has received its first regulatory approval for a [...]

Grifols has expanded its portfolio of plasma-derived therapies in the [...]

PASylated candidate to advance into preclinical development under new agreement [...]